Literature DB >> 15504417

Oncogenic mutations reduce the stability of SRC kinase.

S Fabio Falsone1, Sebastian Leptihn, Anja Osterauer, Martin Haslbeck, Johannes Buchner.   

Abstract

The oncogenic potential of the viral tyrosine kinase v-Src is due to its constitutive activity. Unlike the highly homologous cellular c-Src kinase, a C-terminal deletion of the regulatory tail and numerous point mutations make the viral kinase uncontrollable. To determine the basis of these differences, we analysed the structure and stability of v-Src and c-Src in vitro. We show that the stability of v-Src against unfolding and irreversible aggregation is significantly lower than that of c-Src. Furthermore, in v-Src hydrophobic residues are more exposed already in the native state. In consequence, v-Src was found to be inactive close to physiological temperatures. We thus suggest that the ensemble of mutations that transform c-Src into the oncogenic variant cause a concomitant destabilisation of the kinase.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15504417     DOI: 10.1016/j.jmb.2004.08.091

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  16 in total

Review 1.  HSP90 at the hub of protein homeostasis: emerging mechanistic insights.

Authors:  Mikko Taipale; Daniel F Jarosz; Susan Lindquist
Journal:  Nat Rev Mol Cell Biol       Date:  2010-06-09       Impact factor: 94.444

Review 2.  Protein folding in the cytoplasm and the heat shock response.

Authors:  R Martin Vabulas; Swasti Raychaudhuri; Manajit Hayer-Hartl; F Ulrich Hartl
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-12       Impact factor: 10.005

3.  Conformational processing of oncogenic v-Src kinase by the molecular chaperone Hsp90.

Authors:  Edgar E Boczek; Lasse G Reefschläger; Marco Dehling; Tobias J Struller; Elisabeth Häusler; Andreas Seidl; Ville R I Kaila; Johannes Buchner
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-08       Impact factor: 11.205

Review 4.  The HSP90 chaperone machinery.

Authors:  Florian H Schopf; Maximilian M Biebl; Johannes Buchner
Journal:  Nat Rev Mol Cell Biol       Date:  2017-04-21       Impact factor: 94.444

5.  Bipartite Role of Heat Shock Protein 90 (Hsp90) Keeps CRAF Kinase Poised for Activation.

Authors:  Shahana Mitra; Baijayanti Ghosh; Nilanjan Gayen; Joydeep Roy; Atin K Mandal
Journal:  J Biol Chem       Date:  2016-10-04       Impact factor: 5.157

6.  Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition.

Authors:  Mikko Taipale; Irina Krykbaeva; Martina Koeva; Can Kayatekin; Kenneth D Westover; Georgios I Karras; Susan Lindquist
Journal:  Cell       Date:  2012-08-31       Impact factor: 41.582

Review 7.  Proteomics: a strategy to understand the novel targets in protein misfolding and cancer therapy.

Authors:  Nagathihalli S Nagaraj; Om V Singh; Nipun B Merchant
Journal:  Expert Rev Proteomics       Date:  2010-08       Impact factor: 3.940

8.  Characterization of neuronal Src kinase purified from a bacterial expression system.

Authors:  Vedrana Marin; Bradley R Groveman; Haifa Qiao; Jindong Xu; Mohammad K Ali; Xiao-Qian Fang; Shuang-Xiu Lin; Raed Rizkallah; Myra H Hurt; Ewa A Bienkiewicz; Xian-Min Yu
Journal:  Protein Expr Purif       Date:  2010-06-15       Impact factor: 1.650

9.  Widespread macromolecular interaction perturbations in human genetic disorders.

Authors:  Nidhi Sahni; Song Yi; Mikko Taipale; Juan I Fuxman Bass; Jasmin Coulombe-Huntington; Fan Yang; Jian Peng; Jochen Weile; Georgios I Karras; Yang Wang; István A Kovács; Atanas Kamburov; Irina Krykbaeva; Mandy H Lam; George Tucker; Vikram Khurana; Amitabh Sharma; Yang-Yu Liu; Nozomu Yachie; Quan Zhong; Yun Shen; Alexandre Palagi; Adriana San-Miguel; Changyu Fan; Dawit Balcha; Amelie Dricot; Daniel M Jordan; Jennifer M Walsh; Akash A Shah; Xinping Yang; Ani K Stoyanova; Alex Leighton; Michael A Calderwood; Yves Jacob; Michael E Cusick; Kourosh Salehi-Ashtiani; Luke J Whitesell; Shamil Sunyaev; Bonnie Berger; Albert-László Barabási; Benoit Charloteaux; David E Hill; Tong Hao; Frederick P Roth; Yu Xia; Albertha J M Walhout; Susan Lindquist; Marc Vidal
Journal:  Cell       Date:  2015-04-23       Impact factor: 41.582

Review 10.  The therapeutic target Hsp90 and cancer hallmarks.

Authors:  Yoshihiko Miyata; Hitoshi Nakamoto; Len Neckers
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.